What is the long-term follow-up after the dVP?
Depending on the final pathologic stage of the prostate cancer, a patient may or may not require additional cancer treatments. In either event the mainstay of surveillance will consist of periodic measurement of blood prostate specific antigen (PSA), universally recognized to be the most sensitive indicator of cancer recurrence. The initial surveillance PSA test is drawn at 3 months following surgery and then every 6-12 months thereafter.
